HCID 2779071, compound → HCID 178520776, compound
Reaction equation
Cl.Cl.[O:3]1[C:8]2=[CH:9][CH:10]=[CH:11][C:7]2=[CH:6][C:5]([CH:12]2[CH2:17][CH2:16][CH2:15][CH2:14][N:13]2[CH2:18][CH2:19][C@H:20]2[CH2:25][CH2:24][C@H:23]([NH2:26])[CH2:22][CH2:21]2)=[CH:4]1.[F:27][C:28]([F:36])([F:35])[C@H:29]([OH:34])[CH2:30][C:31](O)=[O:32]>>[O:3]1[C:8]2=[CH:9][CH:10]=[CH:11][C:7]2=[CH:6][C:5]([CH:12]2[CH2:17][CH2:16][CH2:15][CH2:14][N:13]2[CH2:18][CH2:19][C@H:20]2[CH2:21][CH2:22][C@H:23]([NH:26][C:31](=[O:32])[CH2:30][C@@H:29]([OH:34])[C:28]([F:36])([F:35])[F:27])[CH2:24][CH2:25]2)=[CH:4]1Participants
3
Procedure
The title compound, off-white solid (79 mg, 68%), MS (ISP) m/z=467.2 [(M+H)+], mp 166° C., was prepared in accordance with the general method of example 1 from trans-4-[2-(4-benzofuran-3-yl-piperidin-1-yl)-ethyl]-cyclohexylamine dihydrochloride (intermediate A) (100 mg, 0.25 mmol) and (R)-4,4,4-trifluoro-3-hydroxy-butyric acid.
Sources & evidence
- ORD record
- ord-bea5be952c4840dfb60c9b5911718ddc
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921397B2
Reaction notes
Loading…